Day: June 11, 2020

CURE Pharmaceutical[OTC: CURR]Expands Highly Valuable Medication Patent Portfolio; Marketing Expansion to Mexico, Plus New Product Applications in the Multi-Billion Dollar Erectile Dysfunction Market

On June 3rd CURE Pharmaceutical (OTC:CURR), an innovative medication development and enhancement company, announced a collaboration with PMI, a subsidiary of Factoria Bogar in Guadalajara, Mexico. PMI will have access to the CURR bio-product platform, CUREform™ for its medication formulation, and become its distribution partner in Mexico for CURR wellness products, such as […]